US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 93.870
  • -0.280-0.30%
Close Nov 25 16:00 ET
  • 93.870
  • 0.0000.00%
Post 16:20 ET
5.96BMarket Cap-44913P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
86.95%-13.64M
63.16%-48.07M
17.44%-101.51M
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
Net income from continuing operations
57.91%-56.27M
62.35%-50M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
Operating gains losses
--0
---18K
---173.66M
----
----
----
----
----
----
----
Depreciation and amortization
34.51%3.86M
1.09%3.62M
30.56%4.81M
-0.60%11.67M
-78.18%1.53M
77.17%2.87M
143.40%3.58M
126.29%3.68M
81.12%11.74M
321.89%7.02M
Other non cash items
-76.33%1.36M
-58.96%2.76M
-72.18%2.37M
3,511.75%24.39M
-72.17%3.41M
132.67%5.75M
271.50%6.71M
198.95%8.52M
-100.27%-715K
-95.33%12.24M
Change In working capital
420.32%15.46M
4.54%-26.81M
-63.52%-43.2M
23.51%-41.13M
264.99%10.4M
152.24%2.97M
-318.89%-28.08M
51.61%-26.42M
-127.07%-53.77M
-138.06%-6.31M
-Change in receivables
439.15%19.89M
-207.36%-25.07M
-250.35%-17.34M
-242.92%-7.65M
166.30%11.32M
-179.56%-5.87M
-365.41%-8.16M
-212.73%-4.95M
81.09%-2.23M
-133.12%-17.07M
-Change in inventory
-239.36%-4.07M
42.78%-4.69M
3,356.41%2.7M
51.06%-4.37M
-92.93%829K
148.95%2.92M
-68.31%-8.19M
100.79%78K
28.97%-8.92M
1,666.22%11.73M
-Change in prepaid assets
55.75%-619K
-111.03%-7.75M
-93.50%1.02M
118.93%3.21M
-440.28%-7.36M
-289.31%-1.4M
-212.13%-3.67M
179.84%15.64M
-460.92%-16.94M
-121.01%-1.36M
-Change in payables and accrued expense
-22.09%8.27M
469.66%20.69M
-60.66%-25.51M
-16.81%2.96M
713.82%13.81M
964.82%10.62M
-138.43%-5.6M
-110.81%-15.88M
-65.57%3.55M
-112.49%-2.25M
-Change in other current assets
-95.08%-595K
-363.57%-4.65M
-938.85%-4.33M
71.13%-4.71M
32.63%-2.99M
-123.43%-305K
-281.19%-1M
96.97%-417K
-813.77%-16.32M
-519.89%-4.43M
-Change in other current liabilities
-174.69%-7.36M
-84.87%-4.81M
70.50%-2.89M
-120.74%-17.87M
65.34%-2.79M
-11.58%-2.68M
-0.93%-2.6M
-297.98%-9.79M
-1.77%-8.1M
-284.09%-8.06M
-Change in other working capital
80.13%-63K
-147.01%-534K
128.45%3.16M
-163.60%-12.69M
-115.90%-2.41M
94.25%-317K
195.70%1.14M
16.24%-11.1M
-5.04%-4.81M
1,184.05%15.14M
Cash from discontinued investing activities
Operating cash flow
86.95%-13.64M
63.16%-48.07M
17.44%-101.51M
13.03%-436.85M
34.99%-78.93M
19.56%-104.48M
-10.33%-130.48M
7.36%-122.96M
-68.18%-502.28M
-760.17%-121.41M
Investing cash flow
Cash flow from continuing investing activities
412.45%29.95M
-687.20%-188.29M
-55.36%77.13M
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
Net PPE purchase and sale
99.60%-25K
-0.59%-2.57M
57.28%-1.1M
-80.09%-16.06M
-215.53%-4.67M
-67.63%-6.25M
0.08%-2.55M
-124.11%-2.58M
-188.73%-8.92M
-17.73%-1.48M
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
998.83%29.98M
-636.46%-185.72M
-55.39%78.24M
306.73%290.1M
261.08%83.44M
97.40%-3.34M
-56.52%34.62M
539.13%175.38M
-496.63%-140.33M
40.83%-51.8M
Net other investing changes
----
----
----
----
----
----
----
----
---290K
---1K
Cash from discontinued investing activities
Investing cash flow
412.45%29.95M
-687.20%-188.29M
-55.36%77.13M
283.25%274.04M
247.83%78.77M
92.75%-9.59M
-58.39%32.07M
520.52%172.79M
33.79%-149.54M
84.64%-53.28M
Financing cash flow
Cash flow from continuing financing activities
-81.32%18.38M
3,259.98%178.01M
66.96M
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
0
1,007.76%561.81M
-86.11%2.49M
Net issuance payments of debt
--0
--146.8M
---369K
-28.92%97.93M
-218.18%-35K
--97.97M
--0
--0
--137.79M
---11K
Net common stock issuance
--0
--0
--48.94M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
4,163.81%18.38M
489.11%31.21M
--18.4M
160.32%21.34M
521.79%15.61M
-77.60%431K
112.09%5.3M
--0
-83.84%8.2M
-86.00%2.51M
Net other financing activities
----
----
----
-100.01%-44K
----
----
----
----
--415.83M
---8K
Cash from discontinued financing activities
Financing cash flow
-81.32%18.38M
3,259.98%178.01M
--66.96M
-78.78%119.23M
523.36%15.53M
-74.14%98.4M
-97.02%5.3M
--0
1,007.76%561.81M
-86.11%2.49M
Net cash flow
Beginning cash position
-19.91%65.58M
-29.14%123.96M
-34.73%81.52M
-41.94%124.9M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-68.81%215.12M
-46.91%296.62M
Current changes in cash
321.38%34.69M
37.33%-58.35M
-14.55%42.58M
51.58%-43.58M
108.93%15.37M
-113.23%-15.67M
-168.31%-93.11M
128.88%49.83M
81.00%-90.01M
49.82%-172.2M
Effect of exchange rate changes
209.24%591K
-152.54%-31K
-173.60%-145K
197.58%202K
1.88%487K
-42.74%-541K
154.13%59K
200.00%197K
76.69%-207K
194.47%478K
End cash Position
53.59%100.86M
-19.91%65.58M
-29.14%123.96M
-34.73%81.52M
-34.73%81.52M
-77.86%65.67M
-54.15%81.88M
312.87%174.93M
-41.94%124.9M
-41.94%124.9M
Free cash flow
87.66%-13.66M
61.93%-50.64M
18.26%-102.62M
11.40%-452.91M
31.97%-83.6M
17.13%-110.73M
-10.11%-133.03M
6.23%-125.55M
8.70%-511.2M
55.07%-122.89M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 86.95%-13.64M63.16%-48.07M17.44%-101.51M13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M
Net income from continuing operations 57.91%-56.27M62.35%-50M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M
Operating gains losses --0---18K---173.66M----------------------------
Depreciation and amortization 34.51%3.86M1.09%3.62M30.56%4.81M-0.60%11.67M-78.18%1.53M77.17%2.87M143.40%3.58M126.29%3.68M81.12%11.74M321.89%7.02M
Other non cash items -76.33%1.36M-58.96%2.76M-72.18%2.37M3,511.75%24.39M-72.17%3.41M132.67%5.75M271.50%6.71M198.95%8.52M-100.27%-715K-95.33%12.24M
Change In working capital 420.32%15.46M4.54%-26.81M-63.52%-43.2M23.51%-41.13M264.99%10.4M152.24%2.97M-318.89%-28.08M51.61%-26.42M-127.07%-53.77M-138.06%-6.31M
-Change in receivables 439.15%19.89M-207.36%-25.07M-250.35%-17.34M-242.92%-7.65M166.30%11.32M-179.56%-5.87M-365.41%-8.16M-212.73%-4.95M81.09%-2.23M-133.12%-17.07M
-Change in inventory -239.36%-4.07M42.78%-4.69M3,356.41%2.7M51.06%-4.37M-92.93%829K148.95%2.92M-68.31%-8.19M100.79%78K28.97%-8.92M1,666.22%11.73M
-Change in prepaid assets 55.75%-619K-111.03%-7.75M-93.50%1.02M118.93%3.21M-440.28%-7.36M-289.31%-1.4M-212.13%-3.67M179.84%15.64M-460.92%-16.94M-121.01%-1.36M
-Change in payables and accrued expense -22.09%8.27M469.66%20.69M-60.66%-25.51M-16.81%2.96M713.82%13.81M964.82%10.62M-138.43%-5.6M-110.81%-15.88M-65.57%3.55M-112.49%-2.25M
-Change in other current assets -95.08%-595K-363.57%-4.65M-938.85%-4.33M71.13%-4.71M32.63%-2.99M-123.43%-305K-281.19%-1M96.97%-417K-813.77%-16.32M-519.89%-4.43M
-Change in other current liabilities -174.69%-7.36M-84.87%-4.81M70.50%-2.89M-120.74%-17.87M65.34%-2.79M-11.58%-2.68M-0.93%-2.6M-297.98%-9.79M-1.77%-8.1M-284.09%-8.06M
-Change in other working capital 80.13%-63K-147.01%-534K128.45%3.16M-163.60%-12.69M-115.90%-2.41M94.25%-317K195.70%1.14M16.24%-11.1M-5.04%-4.81M1,184.05%15.14M
Cash from discontinued investing activities
Operating cash flow 86.95%-13.64M63.16%-48.07M17.44%-101.51M13.03%-436.85M34.99%-78.93M19.56%-104.48M-10.33%-130.48M7.36%-122.96M-68.18%-502.28M-760.17%-121.41M
Investing cash flow
Cash flow from continuing investing activities 412.45%29.95M-687.20%-188.29M-55.36%77.13M283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M
Net PPE purchase and sale 99.60%-25K-0.59%-2.57M57.28%-1.1M-80.09%-16.06M-215.53%-4.67M-67.63%-6.25M0.08%-2.55M-124.11%-2.58M-188.73%-8.92M-17.73%-1.48M
Net intangibles purchase and sale --------------0------------------0----
Net investment purchase and sale 998.83%29.98M-636.46%-185.72M-55.39%78.24M306.73%290.1M261.08%83.44M97.40%-3.34M-56.52%34.62M539.13%175.38M-496.63%-140.33M40.83%-51.8M
Net other investing changes -----------------------------------290K---1K
Cash from discontinued investing activities
Investing cash flow 412.45%29.95M-687.20%-188.29M-55.36%77.13M283.25%274.04M247.83%78.77M92.75%-9.59M-58.39%32.07M520.52%172.79M33.79%-149.54M84.64%-53.28M
Financing cash flow
Cash flow from continuing financing activities -81.32%18.38M3,259.98%178.01M66.96M-78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M01,007.76%561.81M-86.11%2.49M
Net issuance payments of debt --0--146.8M---369K-28.92%97.93M-218.18%-35K--97.97M--0--0--137.79M---11K
Net common stock issuance --0--0--48.94M----------0--0--0--------
Proceeds from stock option exercised by employees 4,163.81%18.38M489.11%31.21M--18.4M160.32%21.34M521.79%15.61M-77.60%431K112.09%5.3M--0-83.84%8.2M-86.00%2.51M
Net other financing activities -------------100.01%-44K------------------415.83M---8K
Cash from discontinued financing activities
Financing cash flow -81.32%18.38M3,259.98%178.01M--66.96M-78.78%119.23M523.36%15.53M-74.14%98.4M-97.02%5.3M--01,007.76%561.81M-86.11%2.49M
Net cash flow
Beginning cash position -19.91%65.58M-29.14%123.96M-34.73%81.52M-41.94%124.9M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-68.81%215.12M-46.91%296.62M
Current changes in cash 321.38%34.69M37.33%-58.35M-14.55%42.58M51.58%-43.58M108.93%15.37M-113.23%-15.67M-168.31%-93.11M128.88%49.83M81.00%-90.01M49.82%-172.2M
Effect of exchange rate changes 209.24%591K-152.54%-31K-173.60%-145K197.58%202K1.88%487K-42.74%-541K154.13%59K200.00%197K76.69%-207K194.47%478K
End cash Position 53.59%100.86M-19.91%65.58M-29.14%123.96M-34.73%81.52M-34.73%81.52M-77.86%65.67M-54.15%81.88M312.87%174.93M-41.94%124.9M-41.94%124.9M
Free cash flow 87.66%-13.66M61.93%-50.64M18.26%-102.62M11.40%-452.91M31.97%-83.6M17.13%-110.73M-10.11%-133.03M6.23%-125.55M8.70%-511.2M55.07%-122.89M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday+0.82%